Quarterly report [Sections 13 or 15(d)]

Revenue Recognition (Tables)

v3.25.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Service Line

Revenue by Service Line

 

Three Months Ended March 31,

 

(in thousands)

 

2025

 

 

2024

 

Biologics and drug delivery

 

 

 

 

 

 

Disposable products

 

$

1,780

 

 

$

553

 

Services and license fees

 

 

2,911

 

 

 

3,754

 

Subtotal – Biologics and drug delivery revenue

 

 

4,691

 

 

 

4,307

 

Neurosurgery navigation and therapy

 

 

 

 

 

 

Disposable products

 

 

3,277

 

 

 

1,927

 

Services

 

 

 

 

 

 

Subtotal – Neurosurgery navigation and therapy revenue

 

 

3,277

 

 

 

1,927

 

Capital equipment and software

 

 

 

 

 

 

Systems and software products

 

 

234

 

 

 

1,155

 

Services

 

 

283

 

 

 

250

 

Subtotal – Capital equipment and software revenue

 

 

517

 

 

 

1,405

 

Total revenue

 

$

8,485

 

 

$

7,639

 

Schedule of Other Current Assets

(in thousands)

 

March 31, 2025

 

 

December 31, 2024

 

Accounts receivable, net

 

$

3,651

 

 

$

4,713

 

Other contract assets

 

 

 

 

 

 

Unbilled receivables

 

$

804

 

 

$

642

 

Deferred contract costs

 

$

108

 

 

$

 

Schedule of Revenue Recognized by Contract Liability The unearned portion of all such fees is classified as deferred revenue.

(in thousands)

 

March 31, 2025

 

 

December 31, 2024

 

Deferred revenues

 

$

1,975

 

 

$

2,557